Home › Steatotic Liver Disease › Pennsylvania › Philadelphia
Steatotic Liver Disease clinical trials in Philadelphia, PA
4 studies for Steatotic Liver Disease are looking for participants at sites in and around Philadelphia (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
RecruitingPhase 2
- GSK Investigational Site, Philadelphia
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
RecruitingPhase 3
- Akero Clinical Study Site, Philadelphia
- Akero Clinical Study Site, Philadelphia
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
RecruitingPhase 3
- 89bio Clinical Study Site, Philadelphia
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
RecruitingPhase 3
- Penn Medicine: University of Pennsylvania Health System, Philadelphia
- US Digestive Health - Flourtown, Flourtown · 11 mi away
About Steatotic Liver Disease
Steatotic liver disease, formerly called fatty liver disease, happens when too much fat builds up in your liver. Learn about the causes and treatments.
More about Steatotic Liver Disease on MedlinePlus
Steatotic Liver Disease trials in other cities
- Miami, FL17 studies
- San Antonio, TX16 studies
- New York City, NY16 studies
- Houston, TX14 studies
- Austin, TX13 studies
- San Diego, CA12 studies
- Hialeah, FL11 studies
- Richmond, VA11 studies
- New Orleans, LA10 studies
- Orlando, FL10 studies
- Tucson, AZ10 studies
- Cape Coral, FL9 studies
Other studies in Philadelphia
- Cancer (all types)57 studies
- Breast Cancer51 studies
- Non-Small Cell Lung Cancer49 studies
- Ovarian Cancer47 studies
- Metastatic Cancer42 studies
- Colorectal Cancer41 studies
- Prostate Cancer41 studies
- Lung Cancer36 studies
- Acute Myeloid Leukemia33 studies
- Heart Failure31 studies
- Endometrial Cancer29 studies
- Pancreatic Cancer26 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.